Racial differences in outcomes within the National Lung Screening Trial: Implications for widespread implementation

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 2, 2015, Pages 200-208

  Tanner, Nichole T ^a,b   Gebregziabher, Mulugeta ^a,b   Halbert, Chanita Hughes ^a,b,c   Payne, Elizabeth ^b   Egede, Leonard E ^a,b   Silvestri, Gerard A ^b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Lung cancer screening; Mortality; Race

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; CANCER MORTALITY; CANCER SCREENING; CAUCASIAN; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LOW DOSE COMPUTED TOMOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SMOKING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY; AFRICAN AMERICAN; ETHNOLOGY; LUNG; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84938056837     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201502-0259OC     Document Type: Article

References (53)

1. American Cancer Society: Cancer facts and figures. Atlanta: American Cancer Society; 2013.
2. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
3. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
4. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338.
5. Stewart JH IV. Lung carcinoma in African Americans: a review of the current literature. Cancer 2001;91:2476-2482.
6. Higgins RS, Lewis C, Warren WH. Lung cancer in African Americans. Ann Thorac Surg 2003;76:S1363-S1366.
7. Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. Cancer Metastasis Rev 2003;22:39-46.
8. Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev 2006;15:25-31.
9. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198-1205.
10. Ionescu MV, Carey F, Tait IS, Steele RJ. Socioeconomic status and stage at presentation of colorectal cancer. Lancet 1998;352:1439.
11. Wolf MS, Satterlee M, Calhoun EA, Skripkauskas S, Fulwiler D, Diamond-Shapiro L, Alvarez H, Eder M, Mukundan P. Colorectal cancer screening among the medically underserved. J Health Care Poor Underserved 2006;17:47-54.
12. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253.
13. Department of Veteran Affairs Field Research Advisory Committee. Field research advisory committee operating procedures. Veterans Health Administration Office of Research and Development. 2004 [accessed 2015 Jun 19]. Available from: http://www.research.va.gov/resources/frac/FRAC-ops.pdf
14. Cox D. Regression models and life-tables. J R Stat Soc Ser B 1972;34: 187-220.
15. Hougaard P. Survival models for heterogenous populations derived from stable distributions. Biometrika 1986;73:387-396.
16. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. Hoboken, NJ: Wiley; 2002.
17. Hosmer DW, Lemeshow S, May S. Applied survival analysis: regression modeling of time to event data, 2nd ed. Hoboken, NJ: Wiley; 2008.
18. Lin D, Wei L, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993;80:557-572.
19. Grabler P, Dupuy D, Rai J, Bernstein S, Ansell D. Regular screening mammography before the diagnosis of breast cancer reduces black: white breast cancer differences and modifies negative biological prognostic factors. Breast Cancer Res Treat 2012;135:549-553.
20. Njai R, Siegel PZ, Miller JW, Liao Y. Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995-2006. Prev Chronic Dis 2011;8:A59.
21. Centers for Disease Control and Prevention (CDC). Vital signs: racial disparities in breast cancer severity - United States, 2005-2009. MMWR Morb Mortal Wkly Rep 2012;61:922-926.
22. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax 2007;62:126-130.
23. Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen- Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 2003;139:558-563.
24. Keppel KG, Pearcy JN, Heron MP. Is there progress toward eliminating racial/ethnic disparities in the leading causes of death? Public Health Reports 2010;125:689-697.
25. Martinez ME, Cohen RA. Health insurance coverage: early release of estimates from the National Health Interview Survey, January-June 2014. National Center for Health Statistics [released 2014 Sept; accessed 2015 Mar]. Available from: http://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201412.pdf
26. Schiller JS, Ward BW, Freeman G. Early release of selected estimates based on data from the National Health Interview Survey: usual place to go for medical care. National Center for Health Statistics [released 2014 Sept; accessed 2015 Mar]. Available from: http://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201503-02.pdf
27. Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, et al. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial. Clin Trials 2011;8:214-223.
28. Jonnalagadda S, Bergamo C, Lin JJ, Lurslurchachai L, Diefenbach M, Smith C, Nelson JE, Wisnivesky JP. Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer 2012;77:526-531.
29. Tanner NT, Egede LE, Shamblin C, Gebregziabher M, Silvestri GA. Attitudes and beliefs toward lung cancer screening among US veterans. Chest 2013;144:1783-1787.
30. Danaei G, Rimm EB, Oza S, Kulkarni SC, Murray CJ, Ezzati M. The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med 2010;7:e1000248.
31. Surveillance, Epidemiology, and End Results Program. Fast stats: an interactive tool for access to seer cancer statistics. 2010 [accessed 2015 Jun 15]. Available from: http://seer.cancer.gov/faststats
32. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116: 544-573.
33. Wong MD, Ettner SL, Boscardin WJ, Shapiro MF. The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy. J Gen Intern Med 2009;24:475-481.
34. Clegg LX, Ries LAG. Race and ethnicity. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ, editors. Cancer survival among adults: US SEER Program, 1998-2001, patient and tumor characteristics. Bethesda, MD: National Cancer Institute, SEER Program, NIH; 2007. pp. 263-276.
35. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, Le Marchand L. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006;354:333-342.
36. Siahpush M, Singh GK, Jones PR, Timsina LR. Racial/ethnic and socioeconomic variations in duration of smoking: results from 2003, 2006 and 2007 Tobacco Use Supplement of the Current Population Survey. J Public Health (Oxf) 2010;32:210-218.
37. Chen VW. Smoking and the health gap in minorities. Ann Epidemiol 1993;3:159-164.
38. Sellers EM. Pharmacogenetics and ethnoracial differences in smoking. JAMA 1998;280:179-180.
39. Altman DG, Schooler C, Basil MD. Alcohol and cigarette advertising on billboards. Health Educ Res 1991;6:487-490.
40. Lawlor DA, Frankel S, Shaw M, Ebrahim S, Smith GD. Smoking and ill health: does lay epidemiology explain the failure of smoking cessation programs among deprived populations? Am J Public Health 2003;93:266-270.
41. Cutler DM, Lleras-Muney A. Understanding differences in health behaviors by education. J Health Econ 2010;29:1-28.
42. Lutfey K, Freese J. Toward some fundamentals of fundamental causality: socioeconomic status and health in the routine clinic visit for diabetes. Am J Sociol 2005;110:1326-1372.
43. Pampel FC, Rogers RG. Socioeconomic status, smoking, and health: a test of competing theories of cumulative advantage. J Health Soc Behav 2004;45:306-321.
44. Ahluwalia JS, Resnicow K, Clark WS. Knowledge about smoking, reasons for smoking, and reasons for wishing to quit in inner-city African Americans. Ethn Dis 1998;8:385-393.
45. Lynam I, Catley D, Harris KJ, Goggin K, Berkley-Patton J, Thomas J. African American smokers' intention to use pharmacotherapy for cessation. Am J Health Behav 2012;36:615-627.
46. Ryan KK, Garrett-Mayer E, Alberg AJ, Cartmell KB, Carpenter MJ. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res 2011;13:646-652.
47. Royce JM, Hymowitz N, Corbett K, Hartwell TD, Orlandi MA; COMMIT Research Group. Smoking cessation factors among African Americans and whites. Am J Public Health 1993;83:220-226.
48. Murray RP, Connett JE, Buist AS, Gerald LB, Eichenhorn MS. Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tobacco Res 2001;3:375-382.
49. Pederson LL, Ahluwalia JS, Harris KJ, McGrady GA. Smoking cessation among African Americans: what we know and do not know about interventions and self-quitting. Prev Med 2000;31:23-38.
50. U.S. Census Bureau. State and county quickfacts. 2013 [accessed 2015 March 23]. Available from: http://quickfacts.census.gov/qfd/states/00000.html
51. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976-3983.
52. Pinsky PF, Gierada DS, Hocking W, Patz EF Jr, Kramer BS. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 2014;161:627-633.
53. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-254.